Vergoeding 2020-2024 voor ATC-subgroep L04AJ : Complement remmers
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023* | 2024* | |
|---|---|---|---|---|---|
| L04AJ01 Eculizumab | 35.584.078 | 34.429.032 | 36.541.639 | 31.189.951 | 9.282.327 |
| L04AJ02 Ravulizumab | . | . | . | 7.058.589 | 23.863.280 |
| L04AJ03 Pegcetacoplan | . | . | . | . | 114.831 |
| L04AJ04 Sutimlimab | . | . | . | 153.837 | 456.785 |
| Totaal | 35.584.078 | 34.429.032 | 36.541.639 | 38.402.377 | 33.717.223 |